Manorama Industries Limited has announced a robust performance for the financial year ended March 31, 2026. The company reported a 76.1% year-on-year revenue growth to INR 13,577 million, while annual PAT surged by 108.1% to INR 2,332 million. This growth is attributed to a favourable product mix in value-added specialty fats and butter, alongside successful operational optimizations and capacity expansion projects.
Annual Financial Highlights
For the fiscal year 2026, Manorama Industries demonstrated significant operational excellence. The company achieved an annual revenue of INR 13,577 million, marking a substantial increase of 76.1% compared to the previous year. EBITDA also saw remarkable growth, rising 92.5% to INR 3,677 million, with margins expanding by 230 bps to 27.1%. Net profit growth remained a standout feature, climbing 108.1% to INR 2,332 million.
Strategic Growth and Capacity Building
The company continues to scale its manufacturing capabilities. By the end of FY26, Manorama completed the debottlenecking of Solvent Fractionation Plant 2, increasing its capacity by 30% to 32,500 tonnes per annum. Looking ahead, the company has outlined a strategic capital expenditure plan of approximately INR 460 crore over the next 2–3 years. These investments will focus on forward and backward integration, the establishment of a processing plant in Burkina Faso, and the development of new manufacturing facilities for cocoa butter alternatives.
Operational Efficiency and Capital Allocation
Manorama Industries marked a key milestone in FY26, as its annual cash profit exceeded its total gross block, signaling high capital efficiency. The working capital cycle has also seen improvement, reaching approximately 125 days. Reflecting this strong financial health, the Board has announced a final dividend of INR 0.80 per share, representing 40% of the face value. The company remains committed to strengthening its integrated value chain and maintaining its leadership in the global specialty fats and butters market.
Source: BSE
